January 19, 2026 11:15 AM
Dr Reddys Laboratories Ltd Share Price Today Live Updates: Decline by -0.62%
Dr Reddys Laboratories Ltd shares saw a decrease of -0.62%, reaching a current market price of 1168.20. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.
January 19, 2026 10:17 AM
Dr Reddys Laboratories Ltd Share Price Dips in Today's Trading
In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.62% in its share price, and it currently trades at 1168.20 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.
January 19, 2026 9:18 AM
Dr Reddys Laboratories Ltd Tumbles in Today's Trading Session
The stock of Dr Reddys Laboratories Ltd has experienced a -0.20% drop, and it's now trading at 1173.20 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.
January 19, 2026 8:17 AM
Dr Reddys Laboratories Ltd Share Price in Red Today
Dr Reddys Laboratories Ltd share price has declined by -0.08%, and it's currently trading at 1174.60. The stock maintains a PE of 17.1000, while the industry PE is 32.5613, prompting discussions about its valuation.
January 19, 2026 7:17 AM
Dr Reddys Laboratories Ltd Share Price Dips in Today's Trading
In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.33% in its share price, and it currently trades at 1171.60 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.
January 19, 2026 6:17 AM
Dr Reddys Laboratories Ltd Share Price in Red Today: Decline by -0.43%
The stock of Dr Reddys Laboratories Ltd suffered a -0.43% drop, and it's now trading at 1170.50 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.
January 19, 2026 5:16 AM
Live Market Data: Dr Reddys Laboratories Ltd Share Price Down -0.04% Today
Dr Reddys Laboratories Ltd shares saw a -0.04% decrease, reaching a current market price of 1175.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.1000, an ROE of 16.0277 and a debt to equity ratio of 0.1625.